A Simple and Robust Method for Culturing Human‐Induced Pluripotent Stem Cells in an Undifferentiated State Using Botulinum Hemagglutinin. Issue 2 (30th October 2017)
- Record Type:
- Journal Article
- Title:
- A Simple and Robust Method for Culturing Human‐Induced Pluripotent Stem Cells in an Undifferentiated State Using Botulinum Hemagglutinin. Issue 2 (30th October 2017)
- Main Title:
- A Simple and Robust Method for Culturing Human‐Induced Pluripotent Stem Cells in an Undifferentiated State Using Botulinum Hemagglutinin
- Authors:
- Kim, Mee‐Hae
Matsubara, Yoshifumi
Fujinaga, Yukako
Kino‐oka, Masahiro - Abstract:
- Abstract : Clinical and industrial applications of human‐induced pluripotent stem cells (hiPSCs) is hindered by the lack of robust culture strategies capable of sustaining a culture in an undifferentiated state. Here, a simple and robust hiPSC‐culture‐propagation strategy incorporating botulinum hemagglutinin (HA)‐mediated selective removal of cells deviating from an undifferentiated state is developed. After HA treatment, cell–cell adhesion is disrupted, and deviated cells detached from the central region of the colony to subsequently form tight monolayer colonies following prolonged incubation. The authors find that the temporal and dose‐dependent activity of HA regulated deviated‐cell removal and recoverability after disruption of cell–cell adhesion in hiPSC colonies. The effects of HA are confirmed under all culture conditions examined, regardless of hiPSC line and feeder‐dependent or ‐free culture conditions. After routine application of our HA‐treatment paradigm for serial passages, hiPSCs maintains expression of pluripotent markers and readily forms embryoid bodies expressing markers for all three germ‐cell layers. This method enables highly efficient culturing of hiPSCs and use of entire undifferentiated portions without having to pick deviated cells manually. This simple and readily reproducible culture strategy is a potentially useful tool for improving the robust and scalable maintenance of undifferentiated hiPSC cultures. Abstract : The broad developmentalAbstract : Clinical and industrial applications of human‐induced pluripotent stem cells (hiPSCs) is hindered by the lack of robust culture strategies capable of sustaining a culture in an undifferentiated state. Here, a simple and robust hiPSC‐culture‐propagation strategy incorporating botulinum hemagglutinin (HA)‐mediated selective removal of cells deviating from an undifferentiated state is developed. After HA treatment, cell–cell adhesion is disrupted, and deviated cells detached from the central region of the colony to subsequently form tight monolayer colonies following prolonged incubation. The authors find that the temporal and dose‐dependent activity of HA regulated deviated‐cell removal and recoverability after disruption of cell–cell adhesion in hiPSC colonies. The effects of HA are confirmed under all culture conditions examined, regardless of hiPSC line and feeder‐dependent or ‐free culture conditions. After routine application of our HA‐treatment paradigm for serial passages, hiPSCs maintains expression of pluripotent markers and readily forms embryoid bodies expressing markers for all three germ‐cell layers. This method enables highly efficient culturing of hiPSCs and use of entire undifferentiated portions without having to pick deviated cells manually. This simple and readily reproducible culture strategy is a potentially useful tool for improving the robust and scalable maintenance of undifferentiated hiPSC cultures. Abstract : The broad developmental potential of human‐induced pluripotent stem cells (hiPSCs) in industrial and clinical applications is hindered by the lack of robust culture strategies capable of sustaining a culture in an undifferentiated state. In this study, a simple and robust method for culturing hiPSCs in an undifferentiated state is developed by HA‐mediated selective removal of deviating cells. This work provides the robustness and stability of our hiPSC‐culture‐propagation. … (more)
- Is Part Of:
- Biotechnology journal. Volume 13:Issue 2(2018)
- Journal:
- Biotechnology journal
- Issue:
- Volume 13:Issue 2(2018)
- Issue Display:
- Volume 13, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 13
- Issue:
- 2
- Issue Sort Value:
- 2018-0013-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2017-10-30
- Subjects:
- botulinum hemagglutinin -- E‐cadherin disruption -- human‐induced pluripotent stem cells -- removal of deviated cells -- undifferentiated state
Biotechnology -- Periodicals
660.605 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7314 ↗
http://www.biotechnology-journal.com ↗
http://www3.interscience.wiley.com/cgi-bin/jabout/110544531/2446%5Finfo.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/biot.201700384 ↗
- Languages:
- English
- ISSNs:
- 1860-6768
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.862350
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8965.xml